SHP-1 Reverses Trastuzumab Resistance and Migration in HER2-positive Breast Cancer Cells Through the Stat3/P-Stat3 Pathway

Biomedical Research

doi 10.4066/biomedicalresearch.30-17-2421

Full Text

Abstract

Available in

Date

January 1, 2018

Authors

Publisher

OMICS Publishing Group

Related search

Sorafenib Analogue SC-60 Induces Apoptosis Through the SHP-1/STAT3 Pathway and Enhances Docetaxel Cytotoxicity in Triple-Negative Breast Cancer Cells

Molecular Oncology

Cancer Research

Molecular Medicine

English

Correction: Luteolin Selectively Kills STAT3 Highly Activated Gastric Cancer Cells Through Enhancing the Binding of STAT3 to SHP-1

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

Triptolide Blocks the STAT3 Signaling Pathway Through Induction of Protein Tyrosine Phosphatase SHP-1 in Multiple Myeloma Cells

International Journal of Molecular Medicine

English

Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Cancer Research

English

Role of STAT3 Signaling Pathway in Breast Cancer

Cell Communication and Signaling

Molecular Biology

English

Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer

International Journal of Breast Cancer

Cancer Research

English

Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma

Clinical Breast Cancer

Cancer Research

English

Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine

Cancer Management and Research

English

Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English